Catalyst Wire Dossier Catalyst Wire Dossier

ZADAXIN

Thymosin alpha-1 · Sigma-Tau i.f.r. S.p.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZADAXIN, covering 2012-03-29 to 2016-11-29. Get the full timeline:

Most recent: Clinical Trial Update: SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy [Phase 2]

See pricing